Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)
NCT01285167
·
clinicaltrials.gov ↗
COMPLETED
Status
3645
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG:
Daxas
Sponsor
AstraZeneca